Cargando…
Glutamine antagonist JHU083 improves psychosocial behavior and sleep deficits in EcoHIV-infected mice
Combined antiretroviral therapy ushered an era of survivable HIV infection in which people living with HIV (PLH) conduct normal life activities and enjoy measurably extended lifespans. However, despite viral control, PLH often experience a variety of cognitive, emotional, and physical phenotypes tha...
Autores principales: | Bell, Benjamin J., Hollinger, Kristen R., Deme, Pragney, Sakamoto, Shinji, Hasegawa, Yuto, Volsky, David, Kamiya, Atsushi, Haughey, Norman, Zhu, Xiaolei, Slusher, Barbara S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207540/ https://www.ncbi.nlm.nih.gov/pubmed/35734753 http://dx.doi.org/10.1016/j.bbih.2022.100478 |
Ejemplares similares
-
The glutamine antagonist prodrug JHU-083 slows malignant glioma growth and disrupts mTOR signaling
por: Yamashita, Alex Shimura, et al.
Publicado: (2020) -
Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse brain and suppresses the growth of MYC-driven medulloblastoma()()
por: Hanaford, Allison R., et al.
Publicado: (2019) -
Intranasal insulin therapy reverses hippocampal dendritic injury and cognitive impairment in a model of HIV-associated neurocognitive disorders in EcoHIV-infected mice
por: Kim, Boe-Hyun, et al.
Publicado: (2019) -
Protocol for optimizing production and quality control of infective EcoHIV virions
por: Alfar, Hammodah R., et al.
Publicado: (2023) -
Buprenorphine reverses neurocognitive impairment in EcoHIV infected mice: A potential therapy for HIV-NCI
por: Murphy, Aniella J., et al.
Publicado: (2022)